Antibodies used in in vivo rabbit research enable the investigation of immune responses, disease mechanisms, and antibody-mediated biological processes. Depending on their target, specificity, and validated functional properties, these antibodies can neutralize soluble mediators or toxins, modulate receptor activity, or support passive immunization studies. Peer-reviewed research has demonstrated protective effects of monoclonal antibodies in rabbit models of infectious diseases, including anthrax and Staphylococcus aureus pneumonia.

Key Features

• Target specificity: Available as monoclonal or polyclonal antibodies, recognizing a single epitope specificity or multiple epitopes of a target antigen, respectively.

• Functional diversity: Depending on their mechanism of action, selected antibodies may support antigen neutralization, receptor modulation, immune cell depletion, or passive immunization.

• Research applications: Used in immunology, infectious disease research, inflammation studies, and preclinical evaluation of antibody-based interventions.

• Experimental validation: Suitability for in vivo use depends on target specificity, affinity, species compatibility, formulation, and demonstrated biological activity.

Typical Applications

Antibodies used in rabbit models support investigations of immune pathways, target engagement, disease progression, and treatment responses. Selection should account for the intended endpoint, administration route, dose, pharmacokinetic properties, and available validation data. Antibodies validated for Western blotting or immunohistochemistry are not automatically suitable for in vivo administration.